MD Magazine (9/20, Walter) reported that “sertraline (Zoloft), a selective serotonin reuptake inhibitor (SSRI),” appears to lead “to an early reduction in anxiety symptoms commonly found in depression, long before any of the depressive symptoms are reduced,” research indicated. Included in the study were 653 patients. The findings of the “double-blind, placebo-controlled randomized trial” were published online Sept. 19 in The Lancet Psychiatry.
Related Links:
— “Common Antidepressant More Effective for Treating Anxiety, “Kenny Walter, MD Magazine, September 20, 2019